{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T18:47:17Z","timestamp":1763318837189,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jcjo.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T19:24:13Z","timestamp":1576783453000},"page":"e92-e95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proliferative diabetic retinopathy as onset of type 1 diabetes"],"prefix":"10.1016","volume":"55","author":[{"given":"Antonio","family":"Basurto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Vittoria","family":"Cicinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela","family":"Lattanzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2019.09.006_bib0001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1989.01070010243030","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"107","author":"Klein","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ophtha.2009.06.051","article-title":"The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy","volume":"117","author":"Klein","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0003","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/dc12-0863","article-title":"Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy","volume":"36","author":"LeCaire","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0004","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1136\/bjophthalmol-2016-310063","article-title":"Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study","volume":"101","author":"Romero-Aroca","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diacare.24.3.522","article-title":"Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years\u2019 duration screened for the diabetes control and complications trial","volume":"24","author":"Malone","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0006","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/eye.2016.294","article-title":"Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors","volume":"31","author":"Warwick","year":"2017","journal-title":"Eye (Lond)"},{"issue":"Suppl 1","key":"10.1016\/j.jcjo.2019.09.006_bib0007","first-page":"S1","article-title":"Clinical Practice Recommendations 2000","volume":"23","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0008","first-page":"743","article-title":"Screening eye exams in youth with type 1 diabetes under 18 years of age: once may be enough?","volume":"20","author":"Gubitosi-Klug","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0009","article-title":"Guidelines for screening, diagnosis, and treatment of diabetic retinopathy in Italy [Linee-guida per lo screening, la diagnostica e il trattamento della retinopatia diabetica in Italia]","volume":"3","year":"2016","journal-title":"Il Diabete Online, Organo ufficiale della Societ\u00e0 Italiana di Diabetologia"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1600-0420.1996.tb00727.x","article-title":"Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control","volume":"74","author":"Henricsson","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0011","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dmr.5610050703","article-title":"The Wisconsin epidemiological study of diabetic retinopathy: a review","volume":"5","author":"Klein","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0012","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ophtha.2016.10.031","article-title":"Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States","volume":"124","author":"Wang","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0013","first-page":"141","article-title":"Proliferative retinopathy in patients with type 1 diabetes of less than 5 years\u2019 duration","volume":"28","author":"Bouhanick","year":"2002","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9898309","article-title":"Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patients with type 1 diabetes","volume":"2016","author":"Forga","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM198607243150402","article-title":"Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes","volume":"315","author":"Amiel","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2337\/diab.39.9.1116","article-title":"Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II","volume":"39","author":"Orchard","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Lachin","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0018","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajoc.2018.01.006","article-title":"Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: an angiographic illustration","volume":"9","author":"Chandra","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0021","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1167\/iovs.17-23509","article-title":"Mechanistic evaluation of panretinal photocoagulation versus aflibercept in proliferative diabetic retinopathy: CLARITY substudy","volume":"59","author":"Nicholson","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2019.09.006_bib0022","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0002-9394(14)72108-7","article-title":"Spontaneous regression of neovascularization at the disk and elsewhere in diabetic retinopathy","volume":"122","author":"Bandello","year":"1996","journal-title":"Am J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418219307689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418219307689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:09:30Z","timestamp":1757794170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418219307689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0008418219307689"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2019.09.006","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proliferative diabetic retinopathy as onset of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}